We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us

Download Mobile App


ATTENTION: Due to the COVID-19 PANDEMIC, many events are being rescheduled for a later date, converted into virtual venues, or altogether cancelled. Please check with the event organizer or website prior to planning for any forthcoming event.

Biophotonic Treatment Accelerates Burn Wound Healing

By HospiMedica International staff writers
Posted on 16 Aug 2021
Print article
Image: Dr. Praveen Arany, developer of the UB PBM protocol for burn therapy (Photo courtesy of Douglas Levere/UB)
Image: Dr. Praveen Arany, developer of the UB PBM protocol for burn therapy (Photo courtesy of Douglas Levere/UB)
A new study suggests that low dose photobiomodulation (PBM) therapy can speed up recovery and reduce inflammation in third-degree burns.

Researchers at the U.S. National Institute of Dental and Craniofacial Research (NIDCR; Bethesda, MD, USA) and the University at Buffalo (UB; NY, USA) conducted a study to examine the efficacy of PBM treatment in promoting tissue healing and regeneration in a full-thickness burn wound in C57BL/6 mice. PBM was used to activate latent endogenous TGF‐β 1, a protein that controls cell growth and division, including that of immune system cells that lower inflammation, clean cell debris, and fight infection.

The researcher optimized the PBM protocol using an 810 nm continuous wave gallium aluminum arsenide (GaAlAs) laser, and an infrared (IR) camera to monitor tissue surface temperature in order to avoid overheating. They then investigated the roles of individual cell types involved in burn wound healing following PBM treatments and noted discrete effects on epithelieum, fibroblast, and macrophage functions. The responses appeared to be mediated via both TGF-β 1 dependent and independent signaling pathways. The study was published on June 28, 2021, in Nature Scientific Reports.

“This work provides evidence for the ability of PBM-activated TGF-beta one in mitigating the inflammation, while promoting tissue regeneration utilizing an elegant, transgenic burn wound model,” concluded senior author Praveen Arany, DDS, PhD, of the UB School of Dental Medicine, and colleagues. “These mechanistic insights can improve the safety and efficacy of clinical translation of PBM treatments…and may impact therapeutic treatments for burn injuries, which affect more than six million people worldwide each year.”
The clinical benefits of PBM treatments have been demonstrated in the treatment of diabetic, venous, pressure, surgical, burn, and other wounds. Various PBM parameters have been examined in multiple studies, including wavelength (ranging from 660 nm to near-infrared 904 nm), pulsation (0–80 Hz), and doses (2–25 J/cm2).

Related Links:
U.S. National Institute of Dental and Craniofacial Research
University at Buffalo

Print article



view channel

44th IHF World Hospital Congress Presents Over 60 Plenary Sessions and 200 Renowned Speakers Across Four-Day Event

The 44th World Hospital Congress organized by The International Hospital Federation (Geneva, Switzerland) will bring together more than 200 healthcare experts, leading industry thinkers, and best practice... Read more
Copyright © 2000-2021 Globetech Media. All rights reserved.